about
Secretion properties, clearance, and therapy in airway diseaseOral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosisOral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosisOral anti-pseudomonal antibiotics for cystic fibrosisMacrolide antibiotics for cystic fibrosisMacrolide antibiotics for cystic fibrosisOral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosisOral anti-pseudomonal antibiotics for cystic fibrosisCystic fibrosisExacerbations in cystic fibrosis: 2 . prevention.Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis.Mechanisms of action and clinical application of macrolides as immunomodulatory medications.Management of refractory Pseudomonas aeruginosa infection in cystic fibrosisInfluence of macrolide maintenance therapy and bacterial colonisation on exacerbation frequency and progression of COPD (COLUMBUS): study protocol for a randomised controlled trial.New insights into pulmonary inflammation in cystic fibrosis.Surveillance of life-long antibiotics: a review of antibiotic prescribing practices in an Australian Healthcare Network.Azithromycin maintenance therapy in patients with cystic fibrosis: a dose advice based on a review of pharmacokinetics, efficacy, and side effects.Long-term azithromycin therapy in patients with severe COPD and repeated exacerbationsQuorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach.Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa.
P2860
Q21195704-EAE3DF58-BAF9-4CCE-952F-089125CB5679Q24185912-9574F080-9CE5-4B82-9FE3-3398AC298A1FQ24201968-CE39B1A9-449C-4593-8D79-4C92ADF630BBQ24202879-C15DA91C-CCDE-41C1-9E00-82F0232EABA7Q24202885-BA2B14DB-F949-4563-9884-C690F30CAF04Q24234430-566AF72F-2667-4704-A22B-0DC8B82A8F4CQ24243302-C1BA8E7C-AF7E-48EA-80BB-F066D74362B9Q24243916-F70E026A-A0F5-4568-B085-0EC551B0442BQ24680357-C26B5250-51DC-42E2-A55E-9DA942408CE5Q30480308-E3A8BD9E-1302-4C3D-8219-48FC09BD5EEFQ33909856-BC28C778-C083-4D93-836E-487BD513718DQ33983140-07034845-B779-4872-900C-F94412666A76Q35026630-7945897D-F84A-46D7-9E18-A57600344B9FQ36338455-B808A9F1-2F89-43EB-A717-83C98244EEEAQ36573117-31C8780D-DF3A-4B6E-A020-3875475913A9Q37591496-80F830A9-1C96-4FDF-B070-F8FE9927F604Q38017635-9E608C8B-DCBF-4F5A-97FB-D2E543F783B3Q38624850-E923567F-30DF-4E02-B3A5-632F10CB51BDQ42072983-E094DB5C-C2A8-4DBB-86E5-96C918A837AFQ42652660-EB4604DC-6134-47F7-9E50-136940F9803A
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Macrolide antibiotics for cystic fibrosis
@ast
Macrolide antibiotics for cystic fibrosis
@en
Macrolide antibiotics for cystic fibrosis
@en-gb
Macrolide antibiotics for cystic fibrosis
@nl
type
label
Macrolide antibiotics for cystic fibrosis
@ast
Macrolide antibiotics for cystic fibrosis
@en
Macrolide antibiotics for cystic fibrosis
@en-gb
Macrolide antibiotics for cystic fibrosis
@nl
prefLabel
Macrolide antibiotics for cystic fibrosis
@ast
Macrolide antibiotics for cystic fibrosis
@en
Macrolide antibiotics for cystic fibrosis
@en-gb
Macrolide antibiotics for cystic fibrosis
@nl
P2093
P2860
P1476
Macrolide antibiotics for cystic fibrosis
@en
P2093
Arturo Solis-Moya
Kevin W Southern
Latifa Patel
Pierre M Barker
P2860
P356
10.1002/14651858.CD002203.PUB2
P577
2004-04-19T00:00:00Z